(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy
Sun Yat-sen University · Shenzhen University · +19 more institutions
Abstract
Breast cancer is the most malignant tumor in women, and there is no absolute cure for it. Although treatment modalities including surgery, chemotherapy, and radiotherapy are utilized for breast cancer, it is still a life-threatening disease for humans. Nanomedicine has provided a new opportunity in breast cancer treatment, which is the focus of the current study. The nanocarriers deliver chemotherapeutic agents and natural products, both of which increase cytotoxicity against breast tumor cells and prevent the development of drug resistance. The efficacy of gene therapy is boosted by nanoparticles and the delivery of CRISPR/Cas9, Noncoding RNAs, and RNAi, promoting their potential for gene expression…
Citation impact
- FWCI
- 17.10
- Percentile
- 100%
- References
- 349
Authors
15- MAMilad AshrafizadehCorresponding
Sun Yat-sen University, Shenzhen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University
- AZAli Zarrabi
Istinye University
- ABAshkan Bigham
National Research Council, Institute of Polymers, Composites and Biomaterials
- ATAfshin Taheriazam
Islamic Azad University Medical Branch of Tehran
- YSYalda Saghari
Islamic Azad University Medical Branch of Tehran
Topics & keywords
- Nanocarriers
- Medicine
- Immunotherapy
- Breast cancer
- Drug
- Drug delivery
- Cancer
- Genetic enhancement
- Good health and well-being